Circulating hepatocyte growth factor (HGF) in patients with comorbidity of chronic heart failure, type 2 diabetes mellitus and impaired lipid metabolism
AIM: To evaluate the plasma level of circulating heptocyte growth factor (HGF) in patients with comorbidity of post-infarction chronic heart failure (CHF), type 2 diabetes mellitus (T2DM) and obesity. We also aimed to assess possible correlations between HGF levels and parameters of carbohydrate and...
Guardado en:
Autores principales: | Tatiana Nikolaevna Kochegura, P I Makarevich, A G Ovchinnikov, L V Zhigunova, Elena Leonidovna Lahova, Marina Vladimirovna Shestakova, F T Ageev, Elena Viktorovna Parfenova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f104d8b011a41e589949dc791464f62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The influence of concomitant type 2 diabetes mellitus on the number of circulating progenitor cells in patients with ischemiccardiomyopathy
por: Tatiana Nikolaevna Kochegura, et al.
Publicado: (2011) -
Mechanisms of transcriptional control of glucose metabolism in hepatocytes
por: Konstantin Y. Kulebyakin, et al.
Publicado: (2016) -
Изучение количества циркулирующих прогениторных клеток эндотелия у больных сахарным диабетом 1 типа
por: Angelina Valerievna Sokolova, et al.
Publicado: (2015) -
Circulating precursors of endothelial cells in patients with CHD and disturbed carbohydrate metabolism
por: Maria Mikhailovna Ruda, et al.
Publicado: (2010) -
Effect of single intake of exogenous hepatocytes growth inducer on the indices of non-specific resistance under conditions of postresection liver injury
por: S. A. Lepekhova, et al.
Publicado: (2016)